Combinations of oral blood glucose lowering drugs

PheWeb

COMB_ORAL_GLUCLOW

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Medicine purchases: ATC A10BD

7074

Check pre-conditions, main-only, mode, ICD version None

6209

Check minimum number of events

Min. number of events 3

6209

Include endpoints None

6209

COMB_ORAL_GLUCLOW

Extra metadata

First used in FinnGen datafreeze DF2

Similar endpoints

↥

List of similar endpoints to Combinations of oral blood glucose lowering drugs based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	5993	2381	3612
Unadjusted prevalence (%)	1.94	1.37	2.68
Mean age at first event (years)	61.07	60.55	61.42

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.03	2.48 [1.86, 3.30]	4.4e-10	373
15 years	0.01	1.46 [1.09, 1.96]	1.2e-2	214
5 years	0.00	2.81 [2.18, 3.63]	1.4e-15	149
1 year	0.00	1.00 [0.52, 1.91]	1.0e+0	10

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: COMB_ORAL_GLUCLOW – Combinations of oral blood glucose lowering drugs
GWS hits:

Survival analyses between endpoints

↥

Plot

before Combinations of oral blood glucose lowering drugs
after Combinations of oral blood glucose lowering drugs

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Combinations of oral blood glucose lowering drugs

↥